Morphogens function in concentration-dependent manners to instruct cell fate during tissue patterning. The cytoneme morphogen transport model posits that specialized filopodia extend between morphogen-sending and responding cells to ensure that appropriate signaling thresholds are achieved. How morphogens are transported along and deployed from cytonemes, how quickly a cytoneme-delivered, receptor-dependent signal is initiated, and whether these processes are conserved across phyla are not known. Herein, we reveal that the actin motor Myosin 10 promotes vesicular transport of Sonic Hedgehog (SHH) morphogen in mouse cell cytonemes, and that SHH morphogen gradient organization is altered in neural tubes ofMyo10-/-mice. We demonstrate that cytoneme-mediated deposition of SHH onto receiving cells induces a rapid, receptor-dependent signal response that occurs within seconds of ligand delivery. This activity is dependent upon a novel Dispatched (DISP)-BOC/CDON co-receptor complex that functions in ligand-producing cells to promote cytoneme occurrence and facilitate ligand delivery for signal activation.
Breast cancer brain metastasis (BCBM) affects up to 30% of patients with metastatic disease and carries a median survival of only 4–18 months. Emerging evidence reveals that BCBM cells are not passive survivors, but active participants that hijack core neurotransmitter networks, GABA (gamma-aminobutyric acid) and glutamate, to fuel their growth. BCBM, particularly triple-negative breast cancer (TNBC), frequently switch to a GABAergic mode utilizing brain-derived GABA as an oncometabolite. In parallel, BCBM cells can also form direct synapses with neurons, tapping into excitatory input through glutamatergic receptors to drive tumor cell proliferation and survival. Concurrently, reprogrammed astrocytes establish gap junctions, secrete growth factors, and provide metabolic support. Together, tumor cells, neurons, and astrocytes form a pathological partnership locked in feedback loops sustaining metastatic progression. This review focuses on the unique mechanisms employed by distinct breast cancer subtypes and maps the metastatic progression from pre-metastatic to mature brain metastatic niche formation of BCBM. We highlight opportunities to repurpose neurological drugs to disrupt these communication axes.
The Wnt/Wingless (Wg) pathway controls cell fate specification, tissue differentiation and organ development across organisms. Using an in vivo RNAi screen to identify novel kinase and phosphatase regulators of the Wg pathway, we identified subunits of the serine threonine phosphatase Protein phosphatase 4 (PP4). Knockdown of the catalytic and the regulatory subunits of PP4 cause reductions in the Wg pathway targets Senseless and Distal-less. We find that PP4 regulates the Wg pathway by controlling Notch-driven wg transcription. Genetic interaction experiments identified that PP4 likely promotes Notch signaling within the nucleus of the Notch-receiving cell. Although the PP4 complex is implicated in various cellular processes, its role in the regulation of Wg and Notch pathways was previously uncharacterized. Our study identifies a novel role of PP4 in regulating Notch pathway, resulting in aberrations in Notch-mediated transcriptional regulation of the Wingless ligand. Furthermore, we show that PP4 regulates proliferation independent of its interaction with Notch. Summary statement: The protein phosphatase 4 complex promotes Notch signaling and target gene expression during Drosophila wing development.
Tissue morphogenesis and postdevelopmental homeostasis rely on efficient information exchange between communicating cells. Cytonemes are actin-based protrusions that contribute to precise information flow by facilitating contact-mediated directional transport of diverse signaling cargoes. How pathway-specific cytonemes are formed is poorly understood, as are the molecular mechanisms promoting actin organization for elongation and stability of the dynamic cellular extensions. We investigated biogenesis of Sonic Hedgehog (SHH) cytonemes, revealing functional repurposing of cell adhesion molecule-related proteins Brother of CDON (BOC) and Cell adhesion molecule-related, Down-regulated by Oncogenes (CDON) into recruiters of actin regulators FARP1 and Cdc42 for cytoneme elongation. Loss of BOC and CDON function blunts protrusion-localized Cdc42 activity, reducing cytoneme lengths and occurrence in SHH-expressing cells. Live imaging of developing murine spinal cords reveals that CDON loss in SHH-expressing cells reduces the frequency of neuroepithelial cytonemes and alters neuronal cell fate specification. These results inform a model whereby SHH-binding proteins promote ligand transport through stimulating formation of long cytonemes.
Intercellular communication across cancer cells and the tumor microenvironment (TME) is essential for tumor growth, invasion, metastasis, and therapeutic resistance. Traditionally, these interactions have been viewed through the lens of diffusible signaling molecules and extracellular vesicles. However, growing evidence supports an additional paradigm in which specialized cytoskeleton-based membrane extensions, like tunneling nanotubes (TNTs), tumor microtubes (TMs), and cytonemes, mediate direct, contact-dependent communication between cells. This review examines the emerging roles of these cellular extensions in cancer biology, with a particular emphasis on cytonemes, long specialized signaling filopodia that facilitate transport and reception of signaling ligands and receptors. Cytonemes are interwoven with developmental signaling pathways, which are frequently reactivated in cancer, promoting tumor progression. We discuss cytoneme pathology in cancer, with specific examples in growth, stemness, invasion, and microenvironmental remodeling. These extensions represent an unexplored facet of tumor biology and a promising avenue for therapeutic intervention.
About Me
Studying cytoneme biology and morphogen signaling in mammalian development and disease contexts.
Studying cytoneme biology and morphogen signaling in mammalian development and disease contexts.